According to a recent meta-analysis reported by MedicalXpress, mindfulness-based cognitive therapy does not appear to increase the risk of depressive symptom worsening in adults who are already in remission from recurrent depression. For the many of us who have lived through a depressive episode and built our days around the fragile project of staying well, that single sentence carries more weight than it might at first seem. The pooled analysis drew on individual participant data from nine randomized trials and 1,258 adults, comparing symptom trajectories against control conditions.
What the analysis actually examined
Rather than working from summary scores alone, the researchers looked at individual-level data across the nine trials. That matters because it lets you see how each person's symptoms moved over time—not just whether the group average shifted. The participants were adults in remission from depression that had recurred at least once. Half received MBCT; the rest received control comparators. The specific question was direct: did symptom worsening occur more often in the MBCT group than in the controls? Across the pooled dataset, the answer was no—MBCT did not appear to destabilize participants beyond what the comparison conditions did.
Why this reframes a familiar worry
We have often been told, casually or in clinical settings, that to heal you have to feel worse first—that the therapeutic process necessarily reopens old material. When you have a history of recurrent depression, that message can quietly become a barrier to starting anything at all. If you have ever sat in a waiting room wondering whether the next eight weeks will hold you together, you know exactly how heavy that calculation becomes.
What this evidence quietly shifts is the assumption that any internal discomfort during treatment equals harm. Distress is not the same as deterioration, and our nervous systems do not always know the difference on their own. Learning to hold that distinction—between an uncomfortable feeling and a clinical worsening—is one of the more underrated skills in recovery. In many ways, it is the work itself.
There is also a more practical layer here. For clinicians and patients weighing options, the question is no longer only "does it work?" but also "is it safe in the way we had hoped?" This dataset offers an early, partial answer to that second question—one we can carry into our next appointment.
A small habit to take with you
The micro-practice I would offer is this: before you begin any therapy, replace the question "will this hurt?" with two sharper ones—"What does the evidence say about the risk of symptom worsening?" and "How does this protocol define and monitor a setback?" Bring those into the room as a participant in your own care, not as someone waiting for reassurance. That single shift—from fear to informed inquiry—is how we anchor ourselves, even when the work ahead feels uncertain.